I knew I left out 1 or 2 additional very important additional points in regards to Brilacidin and now I remember what those are:
1. I mentioned how Dr. DeGrado's Defensin Mimetic Lab was located at UCSF and the constant stream of proponents it is putting out yearly since 2011 or so. What I failed to mention is that the recently named head of the Biden administration Operation Warp Speed program is Dr. David Kessler, a former head of the FDA who also currently works out of, you guessed it, UCSF. He controls the purse strings and has already indicated TREATMENTS will take a much higher role as opposed to vaccines. Wonder if he is pretty knowledgeable about defensin mimetics? As the old saying goes "Does a bear **** in the woods"?
In addition, 2 or 3 other highly placed doctors in the Biden coronavirus program are also from UCSF. Being in the right place at the right time and knowing the right people sure looks good now.
2. This is an opinion, not a fact, but one has to look at Brilacidin in its entirety as a potential MAJOR factor in not just the CV19 situation but the entire virus problem that faces the world and the fact that Brilacidin appears to transcend many, many boundaries that stymie other drugs. CV19 use should be monstrous for the company, but it is but a single indication (for new eyes each use of a drug for a specific application is known as an indication)and Brilacidin has a spectrum of indications across many areas to include GI tract, viruses, antibiotic, respiratory issues, kidney-related issues, head inflammation, dermatology, ear drops, and a former head of science for IPIX said that they had only scratched the surface of the possible uses for Brilacidin.
3. All examples I have given to date deal ONLY with the small molecule form of Brilacidin. I have not mentioned the biofilm possibilities and this is a multi-billion dollar revenue stream, the fungal opportunities, and the nearly unlimited industrial applications of Brilacidin when it is in a polymer state (a polymer would be many linked small molecules of Brilacidin forming a long sring) and these "strings" could be put into plastics, paints, textiles, and a myriad of other possible industrial products (to name a few school and hospital desks, chairs, and counters, paints, all clothing, bandages, replacement medical apparatus to include knees, hips, elbows, etc, and so many others it is beyond further listing.
There are some I talk with that believe Brilacidin will become a major, major area of investigation by the government for myriad medical and military applications (such as biochemical defense uses) and that outside commercial investigations could become numerous.
The story of Brilacidin is just starting and the world will surely know its name intimately in just a few weeks (as I believe a media blitz is on the VERY NEAR horizon) and its uses will become somewhat of "The Never ending Story".
1. I mentioned how Dr. DeGrado's Defensin Mimetic Lab was located at UCSF and the constant stream of proponents it is putting out yearly since 2011 or so. What I failed to mention is that the recently named head of the Biden administration Operation Warp Speed program is Dr. David Kessler, a former head of the FDA who also currently works out of, you guessed it, UCSF. He controls the purse strings and has already indicated TREATMENTS will take a much higher role as opposed to vaccines. Wonder if he is pretty knowledgeable about defensin mimetics? As the old saying goes "Does a bear **** in the woods"?
In addition, 2 or 3 other highly placed doctors in the Biden coronavirus program are also from UCSF. Being in the right place at the right time and knowing the right people sure looks good now.
2. This is an opinion, not a fact, but one has to look at Brilacidin in its entirety as a potential MAJOR factor in not just the CV19 situation but the entire virus problem that faces the world and the fact that Brilacidin appears to transcend many, many boundaries that stymie other drugs. CV19 use should be monstrous for the company, but it is but a single indication (for new eyes each use of a drug for a specific application is known as an indication)and Brilacidin has a spectrum of indications across many areas to include GI tract, viruses, antibiotic, respiratory issues, kidney-related issues, head inflammation, dermatology, ear drops, and a former head of science for IPIX said that they had only scratched the surface of the possible uses for Brilacidin.
3. All examples I have given to date deal ONLY with the small molecule form of Brilacidin. I have not mentioned the biofilm possibilities and this is a multi-billion dollar revenue stream, the fungal opportunities, and the nearly unlimited industrial applications of Brilacidin when it is in a polymer state (a polymer would be many linked small molecules of Brilacidin forming a long sring) and these "strings" could be put into plastics, paints, textiles, and a myriad of other possible industrial products (to name a few school and hospital desks, chairs, and counters, paints, all clothing, bandages, replacement medical apparatus to include knees, hips, elbows, etc, and so many others it is beyond further listing.
There are some I talk with that believe Brilacidin will become a major, major area of investigation by the government for myriad medical and military applications (such as biochemical defense uses) and that outside commercial investigations could become numerous.
The story of Brilacidin is just starting and the world will surely know its name intimately in just a few weeks (as I believe a media blitz is on the VERY NEAR horizon) and its uses will become somewhat of "The Never ending Story".
9
